1Suppliers
3Customers
2Debt Items
3Related Chains

Avenue Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
DUKE-UNIVERSITY DUKE-UNIVERSITY 92% Under the License Agreement, the Company agreed to make an upfront payment and reimburse certain patent expenses to Duke

Avenue Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
ANNJI ANNJI 92% Under the Termination and Transfer Agreement, AnnJi agreed to pay the Company $ 1.6 million (net of withholding taxes), which was received in 2025.
FBIOP FBIOP 72% Reciprocal relationship from FBIOP graph: Reciprocal relationship from ATXI graph: product candidates and will rely on third parties to manufacture any products for which we receive regulatory approv…
FBIOP FBIOP 72% product candidates and will rely on third parties to manufacture any products for which we receive regulatory approval and their failure to produce them in the volumes that we require on a timely bas…

Avenue Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ATXI-DEBT-7963 Warrants outstanding: 545454 90% xbrl warrant detail from xbrl 2026-03-31.
ATXI-DEBT-7964 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.

Avenue Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Avenue Therapeutics, Inc..

Avenue Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Avenue Therapeutics, Inc..

Avenue Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
FBIOP Fortress Biotech, Inc. 100.00 1 ['customer']
ANNJI ANNJI 63.48 1 ['receiving']
MBIO Mustang Bio, Inc. 50.00 2